Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Global Cellbag Bioreactor Chambers Market Outlook 2020-2030" report has been added to ResearchAndMarkets.com's offering.
Global Cellbag Bioreactor Chambers Market Analysis 2020-2030
The global cellbag bioreactor chambers market is estimated to garner a revenue of more than USD 5120 Million by the end of 2030, up from a revenue of near to USD 1550 Million in the year 2020.
The global cellbag bioreactor chambers market is anticipated to grow with a CAGR of 12.7% over the forecast period, i.e., 2021 - 2030.
Factors such as the increasing trends of cell culture in the field of cellular and molecular biology, along with the growing research and developments in the field of healthcare are projected to drive the market growth.
Moreover, factors such as the increasing prevalence of chronic diseases around the globe and the surge in use of stem cell therapies for the treatment of these chronic diseases, along with other diseases, such as for treating spinal cord injuries, Parkinson's disease, diabetes, Alzheimer's disease, and stroke among others are also anticipated to boost the market growth during the forecast period.
The global cellbag bioreactor chambers market is segmented by numerous segments, which include segmentation by material, component, application, scale, end-user, and by region. By material, the market is segmented into ethylene vinyl acetate copolymer, low density polyethylene, thermoplastic elastomer, polyester, polypropylene, and others.
The polypropylene segment, out of all the other segments, is anticipated to garner the largest revenue of around USD 1260 Million by the end of 2030, up from a revenue of close to USD 370 Million in the year 2020.
The market in North America, amongst the market in all the other regions, is anticipated to garner the largest revenue of near to USD 2270 Million by the end of 2030, up from a revenue of about USD 720 Million in the year 2020.
Some of the prominent industry leaders in the global cellbag bioreactor chambers market
- Thermo Fisher Scientific
- Avantor Inc.
- Global Life Sciences Solutions USA LLC (Cytiva)
- Sartorius AG
- Pall Corporation
- Celltainer Biotech BV
- Adolf Kuhner AG
- Merck KGaA
- TERUMO BCT Inc.
Key Topics Covered:
1. Market Definition
1.1. Definition
1.2. Market Segmentation
2. Assumptions
3. Research Methodology
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
4. Executive Summary - Global Cellbag Bioreactor Chambers Market
5. Supply Chain Analysis
5.1. Analysis on the Key Component Suppliers
5.2. Analysis on the Manufacturers
5.3. Analysis on the End-Users
6. Market Dynamics
6.1. Market Drivers
6.2. Market Trends
7. Major Roadblocks for the Market Growth
8. Key Opportunities
9. Trade Outlook (Export-Import Analysis)
10. Regulatory & Standards Landscape
11. Impact of COVID-19 on the Global Cellbag Bioreactor Chambers Market
12. Pricing Analysis
13. Key Feature Analysis
14. Competitive Structure
14.1. Market Share Analysis, 2020
14.2. Competitive Benchmarking
14.3. Company Profiles
15. Global Cellbag Bioreactor Chambers Market Overview 2020-2030
16. Global Cellbag Bioreactor Chambers Market - Segmentation Analysis 2020-2030
16.1. By Material
16.1.1. Ethylene vinyl acetate copolymer, 2020-2030F (USD million)
16.1.2. Low density polyethylene, 2020-2030F (USD million)
16.1.3. Thermoplastic elastomer, 2020-2030F (USD million)
16.1.4. Polyester, 2020-2030F (USD million)
16.1.5. Polypropylene, 2020-2030F (USD million)
16.1.6. Others, 2020-2030F (USD million)
16.2. By Component
16.2.1. Bioclear films, 2020-2030F (USD million)
16.2.2. Barbed ports, 2020-2030F (USD million)
16.2.3. MCP connectors, 2020-2030F (USD million)
16.2.4. Silicone tubing, 2020-2030F (USD million)
16.2.5. Internal perfusion filters, 2020-2030F (USD million)
16.2.6. Tubing adaptors, 2020-2030F (USD million)
16.2.7. Others, 2020-2030F (USD million)
16.3. By Application
16.3.1. Antibody production, 2020-2030F (USD million)
16.3.2. Virus Production, 2020-2030F (USD million)
16.3.3. Insect Cell Production, 2020-2030F (USD million)
16.3.4. Vaccines, 2020-2030F (USD million)
16.3.5. CGMP Production, 2020-2030F (USD million)
16.3.6. Others, 2020-2030F (USD million)
16.4. By Scale
16.4.1. < 50L, 2020-2030F (USD million)
16.4.2. 50 - 100L, 2020-2030F (USD million)
16.4.3. >100L, 2020-2030F (USD million)
16.5. By End- User
16.5.1. Pharmaceutical Companies, 2020-2030F (USD million)
16.5.2. Biopharmaceutical Companies, 2020-2030F (USD million)
16.5.3. Drug Discovery Companies, 2020-2030F (USD million)
16.5.4. Research Institutes, 2020-2030F (USD million)
16.6. By Region
16.6.1. North America
16.6.2. Europe
16.6.3. Asia Pacific
16.6.4. Latin America
16.6.5. Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/hz44ha
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
